nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—ACHE—kidney cancer	0.542	0.63	CbGaD
Ephedrine—BCHE—kidney cancer	0.319	0.37	CbGaD
Ephedrine—Etomidate—SLC2A1—kidney cancer	0.00341	0.698	CrCbGaD
Ephedrine—Pseudoephedrine—IL2—kidney cancer	0.00106	0.217	CrCbGaD
Ephedrine—Dyspnoea—Temsirolimus—kidney cancer	0.000536	0.00506	CcSEcCtD
Ephedrine—Bradycardia—Sunitinib—kidney cancer	0.000535	0.00505	CcSEcCtD
Ephedrine—Muscle spasms—Everolimus—kidney cancer	0.000527	0.00497	CcSEcCtD
Ephedrine—Decreased appetite—Temsirolimus—kidney cancer	0.000523	0.00493	CcSEcCtD
Ephedrine—Dysuria—Vincristine—kidney cancer	0.000519	0.0049	CcSEcCtD
Ephedrine—Pain—Temsirolimus—kidney cancer	0.000514	0.00485	CcSEcCtD
Ephedrine—Tremor—Everolimus—kidney cancer	0.000513	0.00484	CcSEcCtD
Ephedrine—Insomnia—Pazopanib—kidney cancer	0.000512	0.00483	CcSEcCtD
Ephedrine—Dyspnoea—Pazopanib—kidney cancer	0.000505	0.00476	CcSEcCtD
Ephedrine—Agitation—Everolimus—kidney cancer	0.000503	0.00475	CcSEcCtD
Ephedrine—Dyspepsia—Pazopanib—kidney cancer	0.000498	0.0047	CcSEcCtD
Ephedrine—Vertigo—Vinblastine—kidney cancer	0.000494	0.00466	CcSEcCtD
Ephedrine—Decreased appetite—Pazopanib—kidney cancer	0.000492	0.00464	CcSEcCtD
Ephedrine—Arrhythmia—Sorafenib—kidney cancer	0.000488	0.0046	CcSEcCtD
Ephedrine—Pain—Pazopanib—kidney cancer	0.000484	0.00457	CcSEcCtD
Ephedrine—Palpitations—Everolimus—kidney cancer	0.000484	0.00457	CcSEcCtD
Ephedrine—Body temperature increased—Temsirolimus—kidney cancer	0.000475	0.00448	CcSEcCtD
Ephedrine—Hypertension—Vinblastine—kidney cancer	0.000475	0.00448	CcSEcCtD
Ephedrine—Sweating—Vincristine—kidney cancer	0.000475	0.00448	CcSEcCtD
Ephedrine—Hypertension—Everolimus—kidney cancer	0.000473	0.00446	CcSEcCtD
Ephedrine—Arrhythmia—Sunitinib—kidney cancer	0.00047	0.00443	CcSEcCtD
Ephedrine—Chest pain—Everolimus—kidney cancer	0.000466	0.0044	CcSEcCtD
Ephedrine—Anxiety—Everolimus—kidney cancer	0.000465	0.00439	CcSEcCtD
Ephedrine—Muscle spasms—Sorafenib—kidney cancer	0.000457	0.00431	CcSEcCtD
Ephedrine—Sweating—Gemcitabine—kidney cancer	0.00045	0.00425	CcSEcCtD
Ephedrine—Chest pain—Erlotinib—kidney cancer	0.00045	0.00425	CcSEcCtD
Ephedrine—Anxiety—Erlotinib—kidney cancer	0.000448	0.00423	CcSEcCtD
Ephedrine—Hallucination—Vincristine—kidney cancer	0.000442	0.00417	CcSEcCtD
Ephedrine—Muscle spasms—Sunitinib—kidney cancer	0.00044	0.00415	CcSEcCtD
Ephedrine—Tachycardia—Everolimus—kidney cancer	0.000436	0.00412	CcSEcCtD
Ephedrine—Delirium—Doxorubicin—kidney cancer	0.000432	0.00408	CcSEcCtD
Ephedrine—Hyperhidrosis—Everolimus—kidney cancer	0.000432	0.00408	CcSEcCtD
Ephedrine—Asthenia—Temsirolimus—kidney cancer	0.000431	0.00407	CcSEcCtD
Ephedrine—Anorexia—Vinblastine—kidney cancer	0.000428	0.00404	CcSEcCtD
Ephedrine—Anorexia—Everolimus—kidney cancer	0.000426	0.00402	CcSEcCtD
Ephedrine—Dysuria—Paclitaxel—kidney cancer	0.000413	0.00389	CcSEcCtD
Ephedrine—Anorexia—Erlotinib—kidney cancer	0.000411	0.00388	CcSEcCtD
Ephedrine—Hypertension—Sorafenib—kidney cancer	0.000411	0.00387	CcSEcCtD
Ephedrine—Asthenia—Pazopanib—kidney cancer	0.000406	0.00383	CcSEcCtD
Ephedrine—Insomnia—Everolimus—kidney cancer	0.000404	0.00382	CcSEcCtD
Ephedrine—Irritability—Capecitabine—kidney cancer	0.0004	0.00377	CcSEcCtD
Ephedrine—Dyspnoea—Everolimus—kidney cancer	0.000399	0.00376	CcSEcCtD
Ephedrine—Urinary retention—Capecitabine—kidney cancer	0.000398	0.00376	CcSEcCtD
Ephedrine—Dizziness—Temsirolimus—kidney cancer	0.000397	0.00375	CcSEcCtD
Ephedrine—Hypertension—Sunitinib—kidney cancer	0.000395	0.00373	CcSEcCtD
Ephedrine—Dyspepsia—Everolimus—kidney cancer	0.000394	0.00371	CcSEcCtD
Ephedrine—Insomnia—Erlotinib—kidney cancer	0.00039	0.00368	CcSEcCtD
Ephedrine—Decreased appetite—Vinblastine—kidney cancer	0.00039	0.00368	CcSEcCtD
Ephedrine—Chest pain—Sunitinib—kidney cancer	0.00039	0.00368	CcSEcCtD
Ephedrine—Decreased appetite—Everolimus—kidney cancer	0.000389	0.00367	CcSEcCtD
Ephedrine—Dyspnoea—Erlotinib—kidney cancer	0.000385	0.00363	CcSEcCtD
Ephedrine—Pain—Vinblastine—kidney cancer	0.000384	0.00362	CcSEcCtD
Ephedrine—Pain—Everolimus—kidney cancer	0.000382	0.00361	CcSEcCtD
Ephedrine—Vomiting—Temsirolimus—kidney cancer	0.000382	0.00361	CcSEcCtD
Ephedrine—Dyspepsia—Erlotinib—kidney cancer	0.00038	0.00358	CcSEcCtD
Ephedrine—Rash—Temsirolimus—kidney cancer	0.000379	0.00358	CcSEcCtD
Ephedrine—Dermatitis—Temsirolimus—kidney cancer	0.000379	0.00357	CcSEcCtD
Ephedrine—Arrhythmia—Gemcitabine—kidney cancer	0.000377	0.00356	CcSEcCtD
Ephedrine—Headache—Temsirolimus—kidney cancer	0.000377	0.00355	CcSEcCtD
Ephedrine—Decreased appetite—Erlotinib—kidney cancer	0.000375	0.00354	CcSEcCtD
Ephedrine—Dizziness—Pazopanib—kidney cancer	0.000374	0.00353	CcSEcCtD
Ephedrine—Anorexia—Sorafenib—kidney cancer	0.00037	0.00349	CcSEcCtD
Ephedrine—Feeling abnormal—Vinblastine—kidney cancer	0.00037	0.00349	CcSEcCtD
Ephedrine—Pain—Erlotinib—kidney cancer	0.000369	0.00348	CcSEcCtD
Ephedrine—Feeling abnormal—Everolimus—kidney cancer	0.000368	0.00348	CcSEcCtD
Ephedrine—Vomiting—Pazopanib—kidney cancer	0.00036	0.0034	CcSEcCtD
Ephedrine—Bradycardia—Paclitaxel—kidney cancer	0.00036	0.00339	CcSEcCtD
Ephedrine—Rash—Pazopanib—kidney cancer	0.000357	0.00337	CcSEcCtD
Ephedrine—Nausea—Temsirolimus—kidney cancer	0.000357	0.00337	CcSEcCtD
Ephedrine—Dermatitis—Pazopanib—kidney cancer	0.000357	0.00337	CcSEcCtD
Ephedrine—Anorexia—Sunitinib—kidney cancer	0.000356	0.00336	CcSEcCtD
Ephedrine—Agitation—Vincristine—kidney cancer	0.000356	0.00336	CcSEcCtD
Ephedrine—Headache—Pazopanib—kidney cancer	0.000355	0.00335	CcSEcCtD
Ephedrine—Body temperature increased—Everolimus—kidney cancer	0.000353	0.00333	CcSEcCtD
Ephedrine—Angina pectoris—Capecitabine—kidney cancer	0.000353	0.00333	CcSEcCtD
Ephedrine—Vertigo—Vincristine—kidney cancer	0.000348	0.00328	CcSEcCtD
Ephedrine—Dyspnoea—Sorafenib—kidney cancer	0.000346	0.00326	CcSEcCtD
Ephedrine—Dyspepsia—Sorafenib—kidney cancer	0.000342	0.00322	CcSEcCtD
Ephedrine—Body temperature increased—Erlotinib—kidney cancer	0.000341	0.00322	CcSEcCtD
Ephedrine—Dysuria—Capecitabine—kidney cancer	0.000339	0.00319	CcSEcCtD
Ephedrine—Insomnia—Sunitinib—kidney cancer	0.000338	0.00319	CcSEcCtD
Ephedrine—Decreased appetite—Sorafenib—kidney cancer	0.000337	0.00318	CcSEcCtD
Ephedrine—Anorexia—Dactinomycin—kidney cancer	0.000337	0.00318	CcSEcCtD
Ephedrine—Nausea—Pazopanib—kidney cancer	0.000336	0.00317	CcSEcCtD
Ephedrine—Hypertension—Vincristine—kidney cancer	0.000334	0.00315	CcSEcCtD
Ephedrine—Dyspnoea—Sunitinib—kidney cancer	0.000333	0.00314	CcSEcCtD
Ephedrine—Pain—Sorafenib—kidney cancer	0.000332	0.00313	CcSEcCtD
Ephedrine—Dyspepsia—Sunitinib—kidney cancer	0.000329	0.0031	CcSEcCtD
Ephedrine—Decreased appetite—Sunitinib—kidney cancer	0.000325	0.00306	CcSEcCtD
Ephedrine—Asthenia—Vinblastine—kidney cancer	0.000322	0.00304	CcSEcCtD
Ephedrine—Asthenia—Everolimus—kidney cancer	0.000321	0.00303	CcSEcCtD
Ephedrine—Pain—Sunitinib—kidney cancer	0.000319	0.00301	CcSEcCtD
Ephedrine—Hypertension—Gemcitabine—kidney cancer	0.000317	0.00299	CcSEcCtD
Ephedrine—Arrhythmia—Paclitaxel—kidney cancer	0.000315	0.00298	CcSEcCtD
Ephedrine—Chest pain—Gemcitabine—kidney cancer	0.000313	0.00295	CcSEcCtD
Ephedrine—Asthenia—Erlotinib—kidney cancer	0.00031	0.00292	CcSEcCtD
Ephedrine—Decreased appetite—Dactinomycin—kidney cancer	0.000307	0.0029	CcSEcCtD
Ephedrine—Body temperature increased—Sorafenib—kidney cancer	0.000307	0.00289	CcSEcCtD
Ephedrine—Hyperhidrosis—Vincristine—kidney cancer	0.000305	0.00288	CcSEcCtD
Ephedrine—Pain—Dactinomycin—kidney cancer	0.000302	0.00285	CcSEcCtD
Ephedrine—Tension—Paclitaxel—kidney cancer	0.000302	0.00285	CcSEcCtD
Ephedrine—Anorexia—Vincristine—kidney cancer	0.000301	0.00284	CcSEcCtD
Ephedrine—Nervousness—Paclitaxel—kidney cancer	0.000299	0.00282	CcSEcCtD
Ephedrine—Dizziness—Vinblastine—kidney cancer	0.000297	0.0028	CcSEcCtD
Ephedrine—Dizziness—Everolimus—kidney cancer	0.000296	0.00279	CcSEcCtD
Ephedrine—Muscle spasms—Paclitaxel—kidney cancer	0.000296	0.00279	CcSEcCtD
Ephedrine—Body temperature increased—Sunitinib—kidney cancer	0.000295	0.00279	CcSEcCtD
Ephedrine—Bradycardia—Capecitabine—kidney cancer	0.000295	0.00278	CcSEcCtD
Ephedrine—Feeling abnormal—Dactinomycin—kidney cancer	0.000291	0.00275	CcSEcCtD
Ephedrine—Hyperhidrosis—Gemcitabine—kidney cancer	0.00029	0.00273	CcSEcCtD
Ephedrine—Tremor—Paclitaxel—kidney cancer	0.000288	0.00272	CcSEcCtD
Ephedrine—Insomnia—Vincristine—kidney cancer	0.000286	0.0027	CcSEcCtD
Ephedrine—Anorexia—Gemcitabine—kidney cancer	0.000286	0.0027	CcSEcCtD
Ephedrine—Vomiting—Vinblastine—kidney cancer	0.000285	0.00269	CcSEcCtD
Ephedrine—Dizziness—Erlotinib—kidney cancer	0.000285	0.00269	CcSEcCtD
Ephedrine—Vomiting—Everolimus—kidney cancer	0.000284	0.00268	CcSEcCtD
Ephedrine—Agitation—Paclitaxel—kidney cancer	0.000283	0.00267	CcSEcCtD
Ephedrine—Rash—Everolimus—kidney cancer	0.000282	0.00266	CcSEcCtD
Ephedrine—Dermatitis—Everolimus—kidney cancer	0.000282	0.00266	CcSEcCtD
Ephedrine—Headache—Vinblastine—kidney cancer	0.000281	0.00265	CcSEcCtD
Ephedrine—Headache—Everolimus—kidney cancer	0.00028	0.00264	CcSEcCtD
Ephedrine—Body temperature increased—Dactinomycin—kidney cancer	0.000279	0.00264	CcSEcCtD
Ephedrine—Asthenia—Sorafenib—kidney cancer	0.000278	0.00263	CcSEcCtD
Ephedrine—Vertigo—Paclitaxel—kidney cancer	0.000276	0.00261	CcSEcCtD
Ephedrine—Benzyl alcohol—CYP1A1—kidney cancer	0.000276	0.0565	CrCbGaD
Ephedrine—Decreased appetite—Vincristine—kidney cancer	0.000275	0.00259	CcSEcCtD
Ephedrine—Vomiting—Erlotinib—kidney cancer	0.000274	0.00259	CcSEcCtD
Ephedrine—Rash—Erlotinib—kidney cancer	0.000272	0.00257	CcSEcCtD
Ephedrine—Dermatitis—Erlotinib—kidney cancer	0.000272	0.00256	CcSEcCtD
Ephedrine—Palpitations—Paclitaxel—kidney cancer	0.000272	0.00256	CcSEcCtD
Ephedrine—Insomnia—Gemcitabine—kidney cancer	0.000271	0.00256	CcSEcCtD
Ephedrine—Headache—Erlotinib—kidney cancer	0.00027	0.00255	CcSEcCtD
Ephedrine—Pain—Vincristine—kidney cancer	0.00027	0.00255	CcSEcCtD
Ephedrine—Asthenia—Sunitinib—kidney cancer	0.000268	0.00253	CcSEcCtD
Ephedrine—Dyspnoea—Gemcitabine—kidney cancer	0.000267	0.00252	CcSEcCtD
Ephedrine—Nausea—Vinblastine—kidney cancer	0.000267	0.00252	CcSEcCtD
Ephedrine—Nausea—Everolimus—kidney cancer	0.000266	0.00251	CcSEcCtD
Ephedrine—Hypertension—Paclitaxel—kidney cancer	0.000265	0.0025	CcSEcCtD
Ephedrine—Chest pain—Paclitaxel—kidney cancer	0.000262	0.00247	CcSEcCtD
Ephedrine—Anxiety—Paclitaxel—kidney cancer	0.000261	0.00246	CcSEcCtD
Ephedrine—Decreased appetite—Gemcitabine—kidney cancer	0.00026	0.00246	CcSEcCtD
Ephedrine—Arrhythmia—Capecitabine—kidney cancer	0.000259	0.00244	CcSEcCtD
Ephedrine—Dizziness—Sorafenib—kidney cancer	0.000257	0.00242	CcSEcCtD
Ephedrine—Pain—Gemcitabine—kidney cancer	0.000256	0.00242	CcSEcCtD
Ephedrine—Nausea—Erlotinib—kidney cancer	0.000256	0.00242	CcSEcCtD
Ephedrine—Asthenia—Dactinomycin—kidney cancer	0.000254	0.00239	CcSEcCtD
Ephedrine—Confusional state—Paclitaxel—kidney cancer	0.000253	0.00239	CcSEcCtD
Ephedrine—Body temperature increased—Vincristine—kidney cancer	0.00025	0.00236	CcSEcCtD
Ephedrine—Dizziness—Sunitinib—kidney cancer	0.000247	0.00233	CcSEcCtD
Ephedrine—Feeling abnormal—Gemcitabine—kidney cancer	0.000247	0.00233	CcSEcCtD
Ephedrine—Vomiting—Sorafenib—kidney cancer	0.000247	0.00233	CcSEcCtD
Ephedrine—Tachycardia—Paclitaxel—kidney cancer	0.000245	0.00231	CcSEcCtD
Ephedrine—Rash—Sorafenib—kidney cancer	0.000245	0.00231	CcSEcCtD
Ephedrine—Dermatitis—Sorafenib—kidney cancer	0.000244	0.00231	CcSEcCtD
Ephedrine—Headache—Sorafenib—kidney cancer	0.000243	0.00229	CcSEcCtD
Ephedrine—Muscle spasms—Capecitabine—kidney cancer	0.000243	0.00229	CcSEcCtD
Ephedrine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000243	0.00229	CcSEcCtD
Ephedrine—Anorexia—Paclitaxel—kidney cancer	0.000239	0.00226	CcSEcCtD
Ephedrine—Vomiting—Sunitinib—kidney cancer	0.000237	0.00224	CcSEcCtD
Ephedrine—Body temperature increased—Gemcitabine—kidney cancer	0.000237	0.00224	CcSEcCtD
Ephedrine—Tremor—Capecitabine—kidney cancer	0.000236	0.00223	CcSEcCtD
Ephedrine—Rash—Sunitinib—kidney cancer	0.000235	0.00222	CcSEcCtD
Ephedrine—Dermatitis—Sunitinib—kidney cancer	0.000235	0.00222	CcSEcCtD
Ephedrine—Headache—Sunitinib—kidney cancer	0.000234	0.00221	CcSEcCtD
Ephedrine—Nausea—Sorafenib—kidney cancer	0.000231	0.00218	CcSEcCtD
Ephedrine—Angina pectoris—Doxorubicin—kidney cancer	0.000227	0.00214	CcSEcCtD
Ephedrine—Insomnia—Paclitaxel—kidney cancer	0.000227	0.00214	CcSEcCtD
Ephedrine—Vertigo—Capecitabine—kidney cancer	0.000227	0.00214	CcSEcCtD
Ephedrine—Asthenia—Vincristine—kidney cancer	0.000227	0.00214	CcSEcCtD
Ephedrine—Vomiting—Dactinomycin—kidney cancer	0.000225	0.00212	CcSEcCtD
Ephedrine—Dyspnoea—Paclitaxel—kidney cancer	0.000224	0.00211	CcSEcCtD
Ephedrine—Palpitations—Capecitabine—kidney cancer	0.000223	0.0021	CcSEcCtD
Ephedrine—Rash—Dactinomycin—kidney cancer	0.000223	0.0021	CcSEcCtD
Ephedrine—Nausea—Sunitinib—kidney cancer	0.000222	0.00209	CcSEcCtD
Ephedrine—Dyspepsia—Paclitaxel—kidney cancer	0.000221	0.00208	CcSEcCtD
Ephedrine—Dysuria—Doxorubicin—kidney cancer	0.000218	0.00206	CcSEcCtD
Ephedrine—Decreased appetite—Paclitaxel—kidney cancer	0.000218	0.00206	CcSEcCtD
Ephedrine—Hypertension—Capecitabine—kidney cancer	0.000218	0.00205	CcSEcCtD
Ephedrine—Asthenia—Gemcitabine—kidney cancer	0.000215	0.00203	CcSEcCtD
Ephedrine—Chest pain—Capecitabine—kidney cancer	0.000215	0.00203	CcSEcCtD
Ephedrine—Pain—Paclitaxel—kidney cancer	0.000215	0.00202	CcSEcCtD
Ephedrine—Anxiety—Capecitabine—kidney cancer	0.000214	0.00202	CcSEcCtD
Ephedrine—Nausea—Dactinomycin—kidney cancer	0.00021	0.00198	CcSEcCtD
Ephedrine—Dizziness—Vincristine—kidney cancer	0.000209	0.00197	CcSEcCtD
Ephedrine—Confusional state—Capecitabine—kidney cancer	0.000208	0.00196	CcSEcCtD
Ephedrine—Feeling abnormal—Paclitaxel—kidney cancer	0.000207	0.00195	CcSEcCtD
Ephedrine—Tachycardia—Capecitabine—kidney cancer	0.000201	0.0019	CcSEcCtD
Ephedrine—Vomiting—Vincristine—kidney cancer	0.000201	0.00189	CcSEcCtD
Ephedrine—Sweating—Doxorubicin—kidney cancer	0.000199	0.00188	CcSEcCtD
Ephedrine—Rash—Vincristine—kidney cancer	0.000199	0.00188	CcSEcCtD
Ephedrine—Hyperhidrosis—Capecitabine—kidney cancer	0.000199	0.00188	CcSEcCtD
Ephedrine—Dermatitis—Vincristine—kidney cancer	0.000199	0.00188	CcSEcCtD
Ephedrine—Body temperature increased—Paclitaxel—kidney cancer	0.000198	0.00187	CcSEcCtD
Ephedrine—Headache—Vincristine—kidney cancer	0.000198	0.00187	CcSEcCtD
Ephedrine—Anorexia—Capecitabine—kidney cancer	0.000196	0.00185	CcSEcCtD
Ephedrine—Vomiting—Gemcitabine—kidney cancer	0.000191	0.0018	CcSEcCtD
Ephedrine—Bradycardia—Doxorubicin—kidney cancer	0.00019	0.00179	CcSEcCtD
Ephedrine—Rash—Gemcitabine—kidney cancer	0.000189	0.00178	CcSEcCtD
Ephedrine—Dermatitis—Gemcitabine—kidney cancer	0.000189	0.00178	CcSEcCtD
Ephedrine—Headache—Gemcitabine—kidney cancer	0.000188	0.00177	CcSEcCtD
Ephedrine—Nausea—Vincristine—kidney cancer	0.000188	0.00177	CcSEcCtD
Ephedrine—Insomnia—Capecitabine—kidney cancer	0.000186	0.00176	CcSEcCtD
Ephedrine—Dyspnoea—Capecitabine—kidney cancer	0.000184	0.00173	CcSEcCtD
Ephedrine—Dyspepsia—Capecitabine—kidney cancer	0.000181	0.00171	CcSEcCtD
Ephedrine—Asthenia—Paclitaxel—kidney cancer	0.00018	0.0017	CcSEcCtD
Ephedrine—Decreased appetite—Capecitabine—kidney cancer	0.000179	0.00169	CcSEcCtD
Ephedrine—Nausea—Gemcitabine—kidney cancer	0.000178	0.00168	CcSEcCtD
Ephedrine—Pain—Capecitabine—kidney cancer	0.000176	0.00166	CcSEcCtD
Ephedrine—Feeling abnormal—Capecitabine—kidney cancer	0.00017	0.0016	CcSEcCtD
Ephedrine—Arrhythmia—Doxorubicin—kidney cancer	0.000167	0.00157	CcSEcCtD
Ephedrine—Dizziness—Paclitaxel—kidney cancer	0.000166	0.00157	CcSEcCtD
Ephedrine—Body temperature increased—Capecitabine—kidney cancer	0.000163	0.00154	CcSEcCtD
Ephedrine—Tension—Doxorubicin—kidney cancer	0.00016	0.00151	CcSEcCtD
Ephedrine—Vomiting—Paclitaxel—kidney cancer	0.00016	0.00151	CcSEcCtD
Ephedrine—Rash—Paclitaxel—kidney cancer	0.000158	0.00149	CcSEcCtD
Ephedrine—Dermatitis—Paclitaxel—kidney cancer	0.000158	0.00149	CcSEcCtD
Ephedrine—Nervousness—Doxorubicin—kidney cancer	0.000158	0.00149	CcSEcCtD
Ephedrine—Headache—Paclitaxel—kidney cancer	0.000157	0.00148	CcSEcCtD
Ephedrine—Muscle spasms—Doxorubicin—kidney cancer	0.000156	0.00148	CcSEcCtD
Ephedrine—Agitation—Doxorubicin—kidney cancer	0.000149	0.00141	CcSEcCtD
Ephedrine—Nausea—Paclitaxel—kidney cancer	0.000149	0.00141	CcSEcCtD
Ephedrine—Asthenia—Capecitabine—kidney cancer	0.000148	0.00139	CcSEcCtD
Ephedrine—Vertigo—Doxorubicin—kidney cancer	0.000146	0.00138	CcSEcCtD
Ephedrine—Palpitations—Doxorubicin—kidney cancer	0.000144	0.00136	CcSEcCtD
Ephedrine—Selegiline—ABCB1—kidney cancer	0.000141	0.0288	CrCbGaD
Ephedrine—Hypertension—Doxorubicin—kidney cancer	0.00014	0.00132	CcSEcCtD
Ephedrine—Chest pain—Doxorubicin—kidney cancer	0.000138	0.00131	CcSEcCtD
Ephedrine—Anxiety—Doxorubicin—kidney cancer	0.000138	0.0013	CcSEcCtD
Ephedrine—Dizziness—Capecitabine—kidney cancer	0.000136	0.00128	CcSEcCtD
Ephedrine—Confusional state—Doxorubicin—kidney cancer	0.000134	0.00126	CcSEcCtD
Ephedrine—Vomiting—Capecitabine—kidney cancer	0.000131	0.00124	CcSEcCtD
Ephedrine—Rash—Capecitabine—kidney cancer	0.00013	0.00122	CcSEcCtD
Ephedrine—Dermatitis—Capecitabine—kidney cancer	0.00013	0.00122	CcSEcCtD
Ephedrine—Tachycardia—Doxorubicin—kidney cancer	0.00013	0.00122	CcSEcCtD
Ephedrine—Headache—Capecitabine—kidney cancer	0.000129	0.00122	CcSEcCtD
Ephedrine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000128	0.00121	CcSEcCtD
Ephedrine—Anorexia—Doxorubicin—kidney cancer	0.000127	0.00119	CcSEcCtD
Ephedrine—Nausea—Capecitabine—kidney cancer	0.000122	0.00115	CcSEcCtD
Ephedrine—Insomnia—Doxorubicin—kidney cancer	0.00012	0.00113	CcSEcCtD
Ephedrine—Dyspnoea—Doxorubicin—kidney cancer	0.000118	0.00112	CcSEcCtD
Ephedrine—Dyspepsia—Doxorubicin—kidney cancer	0.000117	0.0011	CcSEcCtD
Ephedrine—Decreased appetite—Doxorubicin—kidney cancer	0.000115	0.00109	CcSEcCtD
Ephedrine—Pain—Doxorubicin—kidney cancer	0.000113	0.00107	CcSEcCtD
Ephedrine—Feeling abnormal—Doxorubicin—kidney cancer	0.000109	0.00103	CcSEcCtD
Ephedrine—Body temperature increased—Doxorubicin—kidney cancer	0.000105	0.00099	CcSEcCtD
Ephedrine—Asthenia—Doxorubicin—kidney cancer	9.52e-05	0.000898	CcSEcCtD
Ephedrine—Dizziness—Doxorubicin—kidney cancer	8.78e-05	0.000828	CcSEcCtD
Ephedrine—Vomiting—Doxorubicin—kidney cancer	8.44e-05	0.000796	CcSEcCtD
Ephedrine—Rash—Doxorubicin—kidney cancer	8.37e-05	0.00079	CcSEcCtD
Ephedrine—Dermatitis—Doxorubicin—kidney cancer	8.36e-05	0.000789	CcSEcCtD
Ephedrine—Headache—Doxorubicin—kidney cancer	8.31e-05	0.000784	CcSEcCtD
Ephedrine—Nausea—Doxorubicin—kidney cancer	7.88e-05	0.000744	CcSEcCtD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	3.95e-05	0.00142	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—RAF1—kidney cancer	3.94e-05	0.00141	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPAT—kidney cancer	3.93e-05	0.00141	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GLIPR1—kidney cancer	3.93e-05	0.00141	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—EIF4EBP1—kidney cancer	3.92e-05	0.00141	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.88e-05	0.00139	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GPC3—kidney cancer	3.85e-05	0.00138	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.84e-05	0.00138	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—PAX6—kidney cancer	3.78e-05	0.00135	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CTSD—kidney cancer	3.76e-05	0.00135	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CA2—kidney cancer	3.74e-05	0.00134	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.74e-05	0.00134	CbGpPWpGaD
Ephedrine—ADRA1A—AMPK Signaling—PIK3CA—kidney cancer	3.72e-05	0.00133	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.72e-05	0.00133	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LATS1—kidney cancer	3.7e-05	0.00133	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—FH—kidney cancer	3.65e-05	0.00131	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APRT—kidney cancer	3.65e-05	0.00131	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ALAD—kidney cancer	3.65e-05	0.00131	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—BRAF—kidney cancer	3.61e-05	0.00129	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—OR4C13—kidney cancer	3.6e-05	0.00129	CbGpPWpGaD
Ephedrine—ADRA1A—AMPK Signaling—TP53—kidney cancer	3.6e-05	0.00129	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.59e-05	0.00129	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.57e-05	0.00128	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ST3GAL2—kidney cancer	3.56e-05	0.00128	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.56e-05	0.00128	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—ACHE—kidney cancer	3.54e-05	0.00127	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.53e-05	0.00127	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—ANXA1—kidney cancer	3.51e-05	0.00126	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—RAF1—kidney cancer	3.51e-05	0.00126	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—EIF4EBP1—kidney cancer	3.5e-05	0.00125	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ALDH1A1—kidney cancer	3.48e-05	0.00125	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (12/13) signalling events—PIK3CA—kidney cancer	3.48e-05	0.00125	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—BCHE—kidney cancer	3.46e-05	0.00124	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.44e-05	0.00123	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GPC3—kidney cancer	3.43e-05	0.00123	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—PAX6—kidney cancer	3.37e-05	0.00121	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKAP13—kidney cancer	3.37e-05	0.00121	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CTSD—kidney cancer	3.35e-05	0.0012	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CA2—kidney cancer	3.34e-05	0.0012	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PGK1—kidney cancer	3.34e-05	0.0012	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SLC5A3—kidney cancer	3.34e-05	0.0012	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—LDHB—kidney cancer	3.27e-05	0.00117	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ALAD—kidney cancer	3.26e-05	0.00117	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—BRAF—kidney cancer	3.22e-05	0.00115	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ST3GAL2—kidney cancer	3.18e-05	0.00114	CbGpPWpGaD
Ephedrine—ACHE—Phospholipid metabolism—PIK3CA—kidney cancer	3.15e-05	0.00113	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AMER1—kidney cancer	3.15e-05	0.00113	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.11e-05	0.00112	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ALDH1A1—kidney cancer	3.11e-05	0.00111	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LATS1—kidney cancer	3.06e-05	0.0011	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKAP13—kidney cancer	3.06e-05	0.0011	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—MAPK1—kidney cancer	3.04e-05	0.00109	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—RAF1—kidney cancer	3.02e-05	0.00108	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PGK1—kidney cancer	2.98e-05	0.00107	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SLC5A3—kidney cancer	2.98e-05	0.00107	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.94e-05	0.00105	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—LDHB—kidney cancer	2.92e-05	0.00105	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—ITPR2—kidney cancer	2.86e-05	0.00103	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.86e-05	0.00103	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CA9—kidney cancer	2.84e-05	0.00102	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.83e-05	0.00102	CbGpPWpGaD
Ephedrine—BCHE—Phospholipid metabolism—PIK3CA—kidney cancer	2.81e-05	0.00101	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.8e-05	0.001	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKAP13—kidney cancer	2.79e-05	0.000998	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.77e-05	0.000994	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	2.73e-05	0.000979	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.7e-05	0.000967	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—RAF1—kidney cancer	2.69e-05	0.000964	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—IGF2—kidney cancer	2.68e-05	0.000959	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.65e-05	0.000948	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GPC3—kidney cancer	2.64e-05	0.000945	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CER1—kidney cancer	2.64e-05	0.000945	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AMER1—kidney cancer	2.6e-05	0.000932	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—ITPR2—kidney cancer	2.6e-05	0.000932	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CA9—kidney cancer	2.53e-05	0.000907	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKAP13—kidney cancer	2.53e-05	0.000907	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	2.52e-05	0.000902	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.47e-05	0.000887	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.43e-05	0.000871	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CRABP1—kidney cancer	2.41e-05	0.000865	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.41e-05	0.000863	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—ANXA1—kidney cancer	2.4e-05	0.00086	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—IGF2—kidney cancer	2.39e-05	0.000856	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.38e-05	0.000853	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—ITPR2—kidney cancer	2.37e-05	0.000849	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.35e-05	0.000843	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	2.26e-05	0.00081	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ITPR2—kidney cancer	2.24e-05	0.000804	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SFRP2—kidney cancer	2.24e-05	0.000803	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CER1—kidney cancer	2.18e-05	0.000781	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GPC3—kidney cancer	2.18e-05	0.000781	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—ANXA1—kidney cancer	2.18e-05	0.000781	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CRABP1—kidney cancer	2.15e-05	0.000771	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—ITPR2—kidney cancer	2.15e-05	0.000771	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—POMC—kidney cancer	2.08e-05	0.000746	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—MAPK1—kidney cancer	2.07e-05	0.000741	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.07e-05	0.000741	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTT1—kidney cancer	2.05e-05	0.000733	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ITPR2—kidney cancer	2e-05	0.000717	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—ANXA1—kidney cancer	1.99e-05	0.000711	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SCARB1—kidney cancer	1.94e-05	0.000694	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS1—kidney cancer	1.92e-05	0.000687	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PSMD7—kidney cancer	1.88e-05	0.000674	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SFRP2—kidney cancer	1.85e-05	0.000664	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—MAPK1—kidney cancer	1.85e-05	0.000661	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.84e-05	0.000661	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ACHE—kidney cancer	1.82e-05	0.000654	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTT1—kidney cancer	1.82e-05	0.000654	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	1.81e-05	0.00065	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKAP13—kidney cancer	1.81e-05	0.000648	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP2—kidney cancer	1.81e-05	0.000648	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—ANXA1—kidney cancer	1.8e-05	0.000646	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—POMC—kidney cancer	1.79e-05	0.00064	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—BCHE—kidney cancer	1.78e-05	0.000639	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SLC5A5—kidney cancer	1.76e-05	0.000631	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SCARB1—kidney cancer	1.73e-05	0.000619	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	1.73e-05	0.000619	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—POMC—kidney cancer	1.72e-05	0.000617	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS1—kidney cancer	1.71e-05	0.000613	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SLC2A1—kidney cancer	1.7e-05	0.000609	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PSMD7—kidney cancer	1.68e-05	0.000601	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—PIK3CA—kidney cancer	1.67e-05	0.0006	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GRB7—kidney cancer	1.65e-05	0.000592	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.65e-05	0.000591	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	1.63e-05	0.000584	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.6e-05	0.000574	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—POMC—kidney cancer	1.59e-05	0.000571	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SLC5A5—kidney cancer	1.57e-05	0.000563	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ITPR2—kidney cancer	1.54e-05	0.000551	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SLC2A1—kidney cancer	1.52e-05	0.000544	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	1.5e-05	0.000537	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP2—kidney cancer	1.49e-05	0.000536	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKAP13—kidney cancer	1.49e-05	0.000536	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.47e-05	0.000527	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.44e-05	0.000515	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTP1—kidney cancer	1.42e-05	0.000508	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CTNNA1—kidney cancer	1.39e-05	0.000499	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EIF4EBP1—kidney cancer	1.38e-05	0.000496	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HSPB1—kidney cancer	1.38e-05	0.000496	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GRB7—kidney cancer	1.37e-05	0.00049	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ABCB1—kidney cancer	1.34e-05	0.000481	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTM1—kidney cancer	1.3e-05	0.000467	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PSMD7—kidney cancer	1.29e-05	0.000461	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TSC1—kidney cancer	1.29e-05	0.000461	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ANXA1—kidney cancer	1.29e-05	0.000461	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.28e-05	0.00046	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CTNNB1—kidney cancer	1.28e-05	0.000457	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ITPR2—kidney cancer	1.27e-05	0.000455	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTP1—kidney cancer	1.26e-05	0.000453	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FLT1—kidney cancer	1.25e-05	0.000447	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYP1A1—kidney cancer	1.24e-05	0.000443	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ABCB1—kidney cancer	1.2e-05	0.000429	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—POMC—kidney cancer	1.18e-05	0.000421	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTM1—kidney cancer	1.16e-05	0.000417	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JUNB—kidney cancer	1.16e-05	0.000414	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PAK1—kidney cancer	1.16e-05	0.000414	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CTNNA1—kidney cancer	1.15e-05	0.000413	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HSPB1—kidney cancer	1.15e-05	0.00041	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EIF4EBP1—kidney cancer	1.15e-05	0.00041	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	1.14e-05	0.000408	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP1A1—kidney cancer	1.1e-05	0.000395	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—POMC—kidney cancer	1.07e-05	0.000383	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PSMD7—kidney cancer	1.06e-05	0.000382	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ANXA1—kidney cancer	1.06e-05	0.000382	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TSC1—kidney cancer	1.06e-05	0.000382	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FLT1—kidney cancer	1.03e-05	0.00037	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.01e-05	0.000364	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—POMC—kidney cancer	9.73e-06	0.000349	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PAK1—kidney cancer	9.56e-06	0.000343	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JUNB—kidney cancer	9.56e-06	0.000343	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF2—kidney cancer	9.45e-06	0.000339	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN2B—kidney cancer	9.41e-06	0.000337	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—POMC—kidney cancer	9.21e-06	0.00033	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF1R—kidney cancer	9.14e-06	0.000327	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.05e-06	0.000324	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—POMC—kidney cancer	8.83e-06	0.000316	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—RAF1—kidney cancer	8.8e-06	0.000315	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—IL2—kidney cancer	8.69e-06	0.000312	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—POMC—kidney cancer	8.22e-06	0.000294	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL2—kidney cancer	7.89e-06	0.000283	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF2—kidney cancer	7.82e-06	0.00028	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN2B—kidney cancer	7.78e-06	0.000279	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF1R—kidney cancer	7.56e-06	0.000271	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HIF1A—kidney cancer	7.52e-06	0.00027	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TSC2—kidney cancer	7.5e-06	0.000269	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS2—kidney cancer	7.35e-06	0.000263	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—RAF1—kidney cancer	7.28e-06	0.000261	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KDR—kidney cancer	7.19e-06	0.000258	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—IL2—kidney cancer	7.19e-06	0.000258	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APC—kidney cancer	6.63e-06	0.000237	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KIT—kidney cancer	6.63e-06	0.000237	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS2—kidney cancer	6.55e-06	0.000235	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL2—kidney cancer	6.53e-06	0.000234	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTEN—kidney cancer	6.41e-06	0.00023	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MAPK3—kidney cancer	6.35e-06	0.000227	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—POMC—kidney cancer	6.31e-06	0.000226	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—BRAF—kidney cancer	6.23e-06	0.000223	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HIF1A—kidney cancer	6.22e-06	0.000223	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TSC2—kidney cancer	6.21e-06	0.000222	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MAPK1—kidney cancer	6.04e-06	0.000216	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KDR—kidney cancer	5.95e-06	0.000213	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CA—kidney cancer	5.77e-06	0.000207	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTEN—kidney cancer	5.72e-06	0.000205	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—KRAS—kidney cancer	5.7e-06	0.000204	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KIT—kidney cancer	5.48e-06	0.000196	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APC—kidney cancer	5.48e-06	0.000196	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MAPK3—kidney cancer	5.25e-06	0.000188	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CA—kidney cancer	5.24e-06	0.000188	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—POMC—kidney cancer	5.22e-06	0.000187	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RAF1—kidney cancer	5.2e-06	0.000186	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RELA—kidney cancer	5.18e-06	0.000186	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BRAF—kidney cancer	5.15e-06	0.000185	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ERBB2—kidney cancer	5.15e-06	0.000184	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MTOR—kidney cancer	5.08e-06	0.000182	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MAPK1—kidney cancer	4.99e-06	0.000179	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	4.77e-06	0.000171	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN1B—kidney cancer	4.77e-06	0.000171	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	4.72e-06	0.000169	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL2—kidney cancer	4.66e-06	0.000167	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCND1—kidney cancer	4.55e-06	0.000163	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JUN—kidney cancer	4.54e-06	0.000163	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CA—kidney cancer	4.52e-06	0.000162	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CTNNB1—kidney cancer	4.5e-06	0.000161	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTEN—kidney cancer	4.39e-06	0.000157	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	4.33e-06	0.000155	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RAF1—kidney cancer	4.3e-06	0.000154	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RELA—kidney cancer	4.28e-06	0.000153	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	4.26e-06	0.000153	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MTOR—kidney cancer	4.2e-06	0.000151	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CA—kidney cancer	4.03e-06	0.000144	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFA—kidney cancer	3.96e-06	0.000142	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	3.94e-06	0.000141	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL2—kidney cancer	3.86e-06	0.000138	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCND1—kidney cancer	3.76e-06	0.000135	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JUN—kidney cancer	3.75e-06	0.000134	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK3—kidney cancer	3.75e-06	0.000134	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	3.72e-06	0.000133	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MYC—kidney cancer	3.65e-06	0.000131	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTEN—kidney cancer	3.63e-06	0.00013	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK1—kidney cancer	3.57e-06	0.000128	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KRAS—kidney cancer	3.37e-06	0.000121	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	3.28e-06	0.000117	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	3.1e-06	0.000111	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CA—kidney cancer	3.1e-06	0.000111	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MYC—kidney cancer	3.02e-06	0.000108	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TP53—kidney cancer	2.99e-06	0.000107	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	2.95e-06	0.000106	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KRAS—kidney cancer	2.79e-06	9.99e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	2.56e-06	9.17e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TP53—kidney cancer	2.48e-06	8.88e-05	CbGpPWpGaD
